Patients and methods
from diagnosis to first radiographic examination.
All patients were treated on one of four successive institutional studies (Total Therapy protocols IX, X, XI and XII), Introduction which have been described previously. [16] [17] [18] In study IX (1975 IX ( -1979 , patients received remission induction therapy with Acute lymphoblastic leukemia (ALL) is the most common prednisone, vincristine, and daunomycin with or without childhood hematologic malignancy.
1 Over the past 40 years, asparaginase and cytarabine. Cranial irradiation of 1800 cGy treatment advances have transformed ALL from a rapidly fatal for lower-risk or 2400 cGy for high-risk patients was adjusted disease to one in which 60-70% of patients survive at least 5 according to the age of the patient. Continuation therapy comyears. 1 However, aggressive chemotherapy and irradiation prised methotrexate and mercaptopurine. In study X (1979-may significantly affect the health and quality of life of long-1983), lower-risk patients were randomized to receive one of term survivors.
2- 14 The dental sequelae in patients treated for two continuation regimens. On one treatment arm, patients ALL are not surprising, because some permanent teeth are received chemotherapy with mercaptopurine and methotrexundergoing active development during childhood, 15 the time ate and pulses of high-dose methotrexate. The other regimen of peak incidence of ALL.
1 Dental development may be comprised cranial irradiation (1800 cGy for low risk and 2400 affected by illness, trauma, chemotherapy, 7, 8, 13, 14 or radiation cGy for high risk) and sequential chemotherapy with three therapy 2-6,13,14 at any point prior to complete maturation. The pairs of drugs (cytarabine-teniposide, cyclophosphamidetiming of the insult within the process of dental development doxorubicin, mercaptopurine-methotrexate). is an important factor.
2,7 Although many of the long-term sideDepending upon their risk features, continuation therapy for effects of aggressive chemotherapy and radiation therapy are patients in study XI (1984) (1985) (1986) (1987) (1988) consisted of mercaptopurine known, the dental sequelae have not been extensively and methotrexate or rotational chemotherapy with paired described and the risk factors remain unclear.
drugs (etoposide-cyclophosphamide, mercaptopurine-methoTo determine the incidence, distribution, and potential pretrexate, cytarabine-teniposide and prednisone-vincristine). disposing factors of dental abnormalities after treatment for Preventative cranial irradiation was given after 1 year of com-ALL (Figure 1) , we reviewed the medical records of 453 plete remission to patients who presented with high-risk feapatients who were followed at our institution during a 16-year tures (1800 cGy) including central nervous system leukemia period; 423 of these patients were evaluable to determine the (2400 cGy). In study XII (1988 XII ( -1991 , patients were ranincidence, distribution, and potential predisposing factors of domized to receive either conventional high-dose methotrexdental abnormalities after treatment for ALL.
ate and teniposide plus cytarabine or individual-adjusted dosage of these agents within a conventional schedule of mercaptopurine-methotrexate. 18 Patients with leukocytosis at diagnosis or t(9;22) rearrangement received preventative cran- son with the total number of patients enrolled on each receiving one panoramic radiograph. The time of the first dental radiograph ranged from diagnosis to 11 years after diagprotocol.
For our evaluation, we divided the study population accordnosis (median 10 months). Age at latest follow-up ranged from 2.4 to 20.3 years (median 9.5 years). The time from the first ing to age at diagnosis (р8 years vs Ͼ8 years, corresponding to two stages of active dental development), chemotherapanoramic radiograph to the second ranged from 17 days to 11.4 years for the 278 patients who had at least two radiopeutic protocol, and treatment with or without radiotherapy. Patients were placed in the 'radiation' group if they received graphic examinations. All 423 patients received multiagent chemotherapy, and cranial irradiation before the first abnormal or last normal panoramic radiograph. Those who did not receive any cranial Table 2 shows the distribution of these patients according to the institutional protocol on which they were enrolled. In irradiation or patients whose radiotherapy occurred after the first abnormal or last normal dental examination were placed addition, cranial irradiation (1800 or 2400 cGy) was given to 243 of the 423 children (55.6%). Eight patients who initially in the 'non-radiation' group. This assignment was made in light of the fact that radiotherapy administered after the identireceived 2400 cGy required retreatment with cranial irradiation because of relapsed disease. Total cranial radiation fication of a dental abnormality cannot have contributed to the development of that abnormality.
doses for these four patients was 4400 cGy. The panoramic radiographs from 256 of the 423 patients Cranial irradiation was given utilizing a 4 MV linear accelerator in 150 cGy fractions with cerrobend blocking. Scatter (60.5%) were free of dental abnormalities at the time of the last examination (median 2.4 years; range, at diagnosis to 14.7 radiation from the cranial field was determined with film dosimetry after exposure in a solid water phantom. A scatter years after diagnosis). We identified dental abnormalities ( Figure 1 ) in the remaining 167 patients (39.5%). Root stunting dose of 10-20% (180-480 cGy) was received by the posterior maxillary molars.
was identified in 103 of the 423 patients (24.4%), microdontia in 80 (18.9%), hypodontia in 36 (8.5%), taurodontism in 25 Dental abnormalities included root stunting (abnormally shortened roots), microdontia (abnormallly small teeth), or (5.9%), and over-retention of primary dentition in 17 (4.0%). Among the patients with microdontia, 24 had aberrant lateral hypodontia (absent teeth). During our review of the panoramic radiographs, we noted an unexpectedly high frequency maxillary incisors and 26 developed abnormal third molars. These patients represent 5.7 and 6.2% of the study population. of taurodontism (abnormally enlarged or elongated pulp cavities), which we then included as a dental abnormality. Figure 1 provides an example of the radiographic appearance of these dental defects. In addition, we attempted to evaluate the frequency of overretention of primary teeth, even though its demonstration is Of the 167 patients who developed dental abnormalities, 119 (71.3%) had normal panoramic radiographs prior to difficult to define accurately. Normal exfoliation times may vary considerably, so we chose a cut-off point of 2 years past detection of the dental defects. The time from normal radiograph to abnormal examination ranged from 9 months to 11.8 the expected age for exfoliation of a given tooth. The frequency, distribution, and time of appearance of dental abnoryears (median 1.7 years). Of the 74 patients that developed more than one type of dental abnormality, four demonstrated malities were recorded. Patients 13 years of age or older who had normal panoramic radiographs were regarded as free of four of the five defects, 12 children showed three of them, and 58 patients had two types. The Total X and XI protocols oncotherapeutic sequelae, even though third molars may not have completed development.
were most frequently associated with patients who had at least two different dental defects (n = 26 and n = 34, respectively). Because of the retrospective nature of this study and the inconsistent radiographic follow-up among patients, detailed Root stunting is extremely rare in the general population, but occurred in about 24% of our study group. Most patients statistical analysis was not done. Evaluation of the results will be descriptive. who developed this defect had received cranial irradiation (82%) or were Ͻ8 years old at diagnosis (86%). Root stunting of molars was the most common finding (n = 103) and reflects the early age of patients at initiation of treatment. Because Results the roots of permanent molars had not developed fully before therapy was initiated, they were more frequently and severely Panoramic radiographs were available for the 423 patients who met our study criteria. There were 219 boys and 204 affected by oncotherapy. In contrast, development of the permanent incisors, bicuspids, canine, and crowns of molars was girls who were 0.6-13.0 years of age (median 4.8 years) when treatment for ALL was initiated. Of these, 359 were white, nearly complete by the time treatment begun in most patients. Microdontia occurred in 18.9% of our patient population. 42 were black and 22 were Hispanic. The number of dental radiographs ranged from one to eight with 145 patients (34%)
As with root-stunting, most patients who developed microdon- had normal examinations (no abnormality ever detected), 35% were older than 13 years at the time of their last examination. Also, 65% who had normal examinations were younger than 13 years at the time of their last panoramic radiograph; 39% of the study population were Ͻ13 years old at the time of last normal examination. These latter groups are still at risk for future dental developmental abnormality. The association between therapy and development of dental abnormalities is corroborated by the number of patients who had normal panoramic radiographs prior to detection of
Figure 1
Panoramic radiograph of an 11-year-old girl diagnosed dental defects. The lag to detectability of dental abnormalities with ALL at the age of 2. years, showing over-retention of mandibular secondary primary molars (arrowheads), anodontia (absence) of all could not be accurately determined due to the retrospective third molars, severe microdontia of all second bicuspids and maxillary nature of the study. However, for 25% of the patients whose second molars (arrows), and severe root stunting of all first permanent normal dental examination was followed by one that demonmolars (long arrows).
strated abnormalities, the abnormality was detected within 1.25 years after the normal examination (range 9 months to 1 year 3 months). This finding, therefore, suggests that periodic tia were young or had received cranial irradiation (89 and panoramic radiographs beginning after the initiation of ther-80%, respectively). In contrast to the rare demonstration of apy may be effective when screening patients with ALL for isolated microdontia in otherwise normal populations, treatment-related dental abnormalities. microdontia of the maxillary lateral incisors was present in Age at treatment and radiation dose have previously been 5.3% (n = 24) of our study population, and 5.7% (n = 26) of implicated in the development of dental abnormalipatients had microdontic third molars. In our series, overties. 6, 13, 14, 19, 20 Cranial irradiation may have influenced the retention was sometimes associated with the absence of perdevelopment of microdontia and root-stunting in our study. manent successors or enlarged pulp chambers.
Although the teeth are not in the field of irradiation, the small amount of scatter radiation coupled with aggressive chemotherapy affects dental development, particularly in the posDiscussion terior maxilla. As little as 1000 cGy can permanently damage mature ameloblasts, and 3000 cGy halts tooth development We found abnormal dental development in many survivors of at the maturational point at which the teeth are irradiated.
6,9
ALL who had received multiagent chemotherapy with or withOwing to the retrospective nature of our study and the short out cranial irradiation when 13 years of age or younger. As mean follow-up period of 3.5 years, we cannot definitely determined by our review of panoramic radiographs, 39% of ascertain the impact of radiation therapy on the development the children studied had microdontia, hypodontia, root-stuntof abnormalities in our study group. However, most patients ing, enlarged pulp chambers, and/or over-retention of primary who developed each of the abnormalities studied had teeth. More than half of the patients in our study population received cranial or craniospinal irradiation. The frequencies began their treatment for ALL before the age of 5. Because of microdontia of the maxillary second and third molars and dental development is very active in children who are 4-6 root stunting of the maxillary second molar were considerably years of age, the high frequency of treatment-related dental greater in the group that received cranial irradiation. The abnormalities in our series is not surprising. With prolonged shape of the radiation ports probably accounts for the larger follow-up, more abnormalities might arise, particularly in number of affected maxillary teeth. In contrast to our expecyounger patients. Our study population represents 40% of tations, we saw an increased incidence of mandibular patients treated at our institution for ALL on four sequential microdontia, taurodontia, and hypodontia of mandibular institutional protocols. Of the study group, 89 patients (21%) molars in our study group. These defects may result from scatwere older than 13 years at the time of their last normal panorter radiation or synergistic effects of scatter radiation (Ͻ5% of amic radiograph and therefore considered at little if any risk for future development of dental abnormalities. Of those who total dose received) and chemotherapy.
Isolated microdontia commonly affects the maxillary lateral effects of radiation and chemotherapy, Goho 9 stated that these treatment modalities might affect dental exfoliation and erupincisors and third molars of otherwise healthy children. 21 However, this abnormality was present in the bicuspids, cantion. Because normal exfoliation of primary teeth is associated with the maturation and eruption of permanent teeth, 15 any ines, incisors, and/or molars of nearly 19% of our study population, suggesting an association between these defects and factor interfering with dental development could result in over-retention of the primary teeth. The relationship between therapy for ALL. Hypodontia and microdontia can cause abnormal spacing and drifting of teeth, potentially resulting in chemotherapy and over-retention of primary dentition requires further investigation. poor dental alignment, malocclusion, and dysfunction of the temporomandibular joint. In addition, hypodontia or rootDental abnormalities are common in patients treated for ALL, and these children require aggressive dental follow-up. stunting preclude adequate orthodontic anchorage 19, 22 and place these teeth at added risk for the damaging effects of Meticulous surveillance (clinical and radiographic) may facilitate detection of abnormalities, enabling the dental pracgingival and periodontal disease. 13, 14 Taurodontism, characterized radiographically by abnortitioner to intervene earlier in promoting a more aggressive regimen of oral care, thus reducing the morbidity associated mally enlarged and elongated pulp chambers in both primary and permanent teeth, has a reported incidence of 0.5-11.3%
with dental sequelae of oncotherapy, specifically periodontal disease and malocclusion. Pending the results of prospective in otherwise healthy children. 23 Recognized since 1913, this clinical entity represents a delay in the development and prostudies to determine more accurately the incidence and lag to developing dental abnormalities among children treated for per positioning of Hertwig's root sheath after formation of the tooth crown resulting in the apical displacement of the pulpal ALL, and based on our observations of time elapsed from the beginning of therapy to the development of dental abnormalifloor and furcation area. 24 Llamas and Jimenez-Planas 25 suggested that genetic factors might affect the timely development ties, we recommend completion of a baseline dental study within 6 months of the start of treatment (or as soon as the of Hertwig's root sheath in cases of nontreatment-related taurodontism. This abnormality most frequently affects molars, patient can cooperate in obtaining a panoramic radiograph).
In the absence of other clinical indications, we feel that the but has been reported to occur in premolars. 24 The clinical importance of taurodontism lies in the thinned, shortented next radiographic follow-up should occur about 18 months later, followed by panoramic radiographs obtained every 2 root structure of the involved teeth, which are thus more vulnerable to periodontal disease and less amenable to years. orthodontic correlation.
To our knowledge, only two previous reports have mentioned taurodontism in relation to oncotherapy, and the freAcknowledgements quency of this abnormality was not quantified in either study. 26, 27 Early-age chemotherapy may retard the developWe thank Alicia Le for data management, Sharon Naron and ment of Hertwig's root sheath by interfering with epithelioAmy LB Frazier for assistance in manuscript preparation, and mesenchymatose induction during the odontogenic process.
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28-31 In our series, 25 patients developed tauroReferences dontism, six of whom were seen within the first year after diagnosis and therefore, uncertainly related to therapy. comprised chemotherapy alone. 6 In a review addressing the
